Live Breaking News & Updates on Rajiv malik

Stay updated with breaking news from Rajiv malik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Belgium based Eurofins inaugurates BioPharma Services Campus in Genome Valley

Hyderabad: Belgium headquartered Eurofins, the world leader in testing for life, has inaugurated its state-of-the-art, BioPharma Services Campus in Genome Valley.Coming up in 15 acres land with an...

Telangana , Andhra-pradesh , India , Belgium , Hyderabad , Eurofins-advinus , Kt-rama-rao , Ev-narasimha-reddy , Shakthim-nagappan , Neeraj-garg , Rajiv-malik , Life-sciences

Belgium firm Eurofins opens bio-pharma services campus at Genome Valley

Belgium firm Eurofins opens bio-pharma services campus at Genome Valley
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

India , Hyderabad , Andhra-pradesh , Kt-rama-rao , Eurofins-neeraj-garg , Eurofins-advinus , Rajiv-malik , Life-sciences , Genome-valley , Doing-business ,

Eurofins opens ₹150-cr biopharma services centre in Hyderabad

Eurofins opens ₹150-cr biopharma services centre in Hyderabad
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Hyderabad , Andhra-pradesh , India , Telangana , Belgium , Bengaluru , Karnataka , Eurofins-advinus , Neeraj-garg , Rajiv-malik , Rama-rao , Facebook

FDA refuses to okay first nasal spray for allergic reactions, firm says

FDA refuses to okay first nasal spray for allergic reactions, firm says
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

Eric-karas , William-blair , Richard-lowenthal , Tim-lugo , Rajiv-malik , Allergy-drugs-advisory-committee , Drug-administration , Pulmonary-allergy-drugs-advisory-committee ,

Viatris Inc. (NASDAQ:VTRS) Q2 2023 Earnings Call Transcript

Operator: Good morning. My name is Todd, and I will be your conference operator today. At this time, I would like to welcome everyone to the Viatris 2023 Second Quarter Earnings Call and Webcast.

United-states , China , Japan , Italy , Spain , United-kingdom , America , William-szablewski , Rajiv-malik , Jason-gerberry , Glenn-santangelo , Sanjeev-narula

FDA decision on GA Depot for relapsing MS expected March 2024 | Multiple Sclerosis News Today

FDA decision on GA Depot for relapsing MS expected March 2024 | Multiple Sclerosis News Today
multiplesclerosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from multiplesclerosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

Ehud-marom , Rajiv-malik , Mapi-pharma , Drug-administration , Mapi-sponsored-phase ,

Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Reaffirms Full-Year 2023 Guidance Ranges[1]

$
Free Cash Flow
$2,300 - $2,700
___________

Includes the full year expected performance for the planned divestitures and excludes any potential related costs, such as taxes and transaction costs,...

China , Shanghai , India , United-states , Hyderabad , Andhra-pradesh , Scotta-smith , Biocon-biologics , Sanjeev-narula , Rajiv-malik , Viatris-inc , Pfizer-inc

Viatris and Mapi Pharma Announce FDA Acceptance of New Drug Application Filing for GA Depot for the Treatment of Relapsing Forms of Multiple Sclerosis

FDA assigns PDUFA target action date of March 8, 2024
New Drug Application supported by positive Phase III efficacy and safety clinical trial results
Milestone builds upon Viatris' long-standing and...

China , Shanghai , Israel , India , Hyderabad , Andhra-pradesh , Mapi-pharma , Ehud-marom , Fingolimod-gilenya , Apremilast-otezla , Rajiv-malik , Drug-administration

Viatris, Mapi Pharma: FDA Accepts For Review NDA For GA Depot To Treat RMS

(RTTNews) - Healthcare company Viatris Inc. (VTRS) and Mapi Pharma Ltd., a late-stage clinical development pharmaceutical company, announced Monda...

Rajiv-malik , Drug-administration , Mapi-pharma-ltd , Viatris-inc , More-such-health-news , New-drug-application , Glatiramer-acetate , Prescription-drug-user-fee-act , Injection-site-reactions , President-rajiv-malik , Primary-progressive-multiple-sclerosis ,

Viatris Shares Gain on Sales, Divestitures, and FDA Review of Its MS Drug

Viatris shares advanced after the drugmaker posted better-than-expected results, said it will announce one or more divestitures this quarter, and indicated the FDA agreed to consider approval of its new multiple sclerosis treatment produced with Israel’s Mapi Pharma.

Israel , Scott-smith , Mapi-pharma , Rajiv-malik , Drug-administration , New-drug-application ,